A detailed history of Israel Englander (Millennium Management LLC) transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 37,704 shares of NAUT stock, worth $33,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,704
Holding current value
$33,556
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.67 - $2.96 $62,965 - $111,603
37,704 New
37,704 $63,000
Q1 2024

May 15, 2024

BUY
$2.41 - $3.18 $22,801 - $30,085
9,461 Added 84.65%
20,637 $60,000
Q4 2023

Feb 14, 2024

BUY
$2.34 - $3.39 $26,151 - $37,886
11,176 New
11,176 $33,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $111M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.